Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas

被引:46
作者
Kaibori, Masaki [1 ]
Ishizaki, Morihiko [1 ]
Saito, Takamichi [1 ]
Matsui, Kosuke [1 ]
Kwon, A-Hon [1 ]
Kamiyama, Yasuo [1 ]
机构
[1] Kansai Med Univ, Dept Surg, Hirakata Hosp, Osaka 5731191, Japan
关键词
Small hepatocellular carcinoma; Hepatic resection; Early recurrence; Risk factor; PERCUTANEOUS ETHANOL INJECTION; VIRUS-RELATED CIRRHOSIS; LOCAL ABLATIVE THERAPY; LONG-TERM PROGNOSIS; INTRAHEPATIC RECURRENCE; CURATIVE RESECTION; ADJUVANT CHEMOTHERAPY; LIVER; HEPATECTOMY; SURGERY;
D O I
10.1016/j.amjsurg.2008.07.051
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: This study aimed to clarify risk factors for early recurrence and examine the subsequent Outcome in patients undergoing potentially R0 resection of small hepatocellular carcinomas (HCCs) (<= 52 cm in greatest dimension). METHODS: Eighty-nine patients were divided into 2 groups as follows: 26 patients suffering from recurrence within 2 years of surgery (early recurrence group) and 63 patients who were disease-free for at least 2 years (disease-free 2Y group). RESULTS: Only 7 of 63 patients (11%) from the group that was disease-free for at least 2 years died during the 5-year period after surgery, whereas 13 of 26 patients (50%) from the early recurrence group died. Multivariate analysis showed that the preoperative maximum removal rate of technetium-99m-diethylenetriamine pentaacetic acid-galactosyl human serum albumin and microscopic vascular invasion were independent predictors of the early recurrence of small HCC. CONCLUSIONS: Early recurrence of small HCC is the leading cause of death within 5 years after R0 resection. The preoperative hepatic functional reserve influences early recurrence, even in patients with small tumors. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 50 条
  • [1] Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
    Arii, S
    Yamaoka, Y
    Futagawa, S
    Inoue, K
    Kobayashi, K
    Kojiro, M
    Makuuchi, M
    Nakamura, Y
    Okita, K
    Yamada, R
    [J]. HEPATOLOGY, 2000, 32 (06) : 1224 - 1229
  • [2] Epidemiology of primary liver cancer
    Bosch, FX
    Ribes, J
    Borràs, J
    [J]. SEMINARS IN LIVER DISEASE, 1999, 19 (03) : 271 - 285
  • [3] Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results
    Buscarini, L
    Buscarini, E
    Di Stasi, M
    Vallisa, D
    Quaretti, P
    Rocca, A
    [J]. EUROPEAN RADIOLOGY, 2001, 11 (06) : 914 - 921
  • [4] CASTELLS A, 1993, HEPATOLOGY, V18, P1121
  • [5] A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
    Chen, MS
    Li, JQ
    Zheng, Y
    Guo, RP
    Liang, HH
    Zhang, YQ
    Lin, XJ
    Lau, WY
    [J]. ANNALS OF SURGERY, 2006, 243 (03) : 321 - 328
  • [6] Couinaud C., 1957, FOIE ETUDES ANATOMIQ, P400
  • [7] Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
    Degos, F
    Christidis, C
    Ganne-Carrie, N
    Farmachidi, JP
    Degott, C
    Guettier, C
    Trinchet, JC
    Beaugrand, M
    Chevret, S
    [J]. GUT, 2000, 47 (01) : 131 - 136
  • [8] Rising incidence of hepatocellular carcinoma in the United States
    El-Serag, HB
    Mason, AC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) : 745 - 750
  • [9] Liver transplantation for hepatocellular carcinoma
    Hemming, AW
    Cattral, MS
    Reed, AI
    Van der Werf, WJ
    Greig, PD
    Howard, RJ
    [J]. ANNALS OF SURGERY, 2001, 233 (05) : 652 - 658
  • [10] The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States
    Hu, KQ
    Tong, MJ
    [J]. HEPATOLOGY, 1999, 29 (04) : 1311 - 1316